Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.
Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.
Systematic approaches to central nervous system myelin.
Assessment of cerebral venous return by a novel plethysmography method.
Transverse myelitis associated with heroin and cannabis abuse: a new issue from the past.
Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.
Natalizumab in the treatment of rheumatoid arthritis in subjects receiving methotrexate
Ocrelizumab in multiple sclerosis: risks and benefits.
Validity and Reliability of a Persian Translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Receptos begins enrollment of Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.
Focused suggestion with somatic anchoring technique: rapid self-hypnosis for pain management.
Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis.
Oligodendrocytes Enforce Immune Tolerance of the Uninfected Brain by Purging the Peripheral Repertoire of Autoreactive CD8(+) T Cells.
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis.
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator.
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis.
Unraveling the secrets of white matter - Bridging the gap between cellular, animal and human imaging studies.
QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.
Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex.
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Association between Change in Normal Appearing White Matter Metabolites and Intrathecal Inflammation in Natalizumab-Treated Multiple Sclerosis.

Pages